← SynDRA
URIDINE
SynDRA canonical compound SYN0003859 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | LSM6 | TYMP |
| Mechanism of action | dopamine receptor agonist |
All known targets
Mechanisms of action (all sources)
- dopamine receptor agonist
- TYMP INHIBITOR
Cross-references
Synonyms
- 1-.beta.-d-ribofuranosyluracil
- Uracil riboside
- NSC-20256
- Uridin
- beta-Uridine
- d-uridine
- CHEBI:16704
- b-Uridine
- UNII-WHI7HQ7H85
- Urd
- AI3-52690
- EINECS 200-407-5
- WHI7HQ7H85
- MLS000069625
- Uracil-1-beta-d-ribofuranoside
- C9H12N2O6
- DRTQHJPVMGBUCF-XVFCMESISA-N
- SMR000058222
- 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
- 1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione
- uridine (usp impurity)
- uridine (usp-rs)
- NSC 20256
- adenosine impurity f (ep impurity)
- 1-beta-D-Ribofuranosyluracil
- NSC20256
- Allo-Uridine
- RefChem:6340
- DTXCID001030648
- Uracil, 1-beta-D-ribofuranosyl-
- MFCD00006526
- 1-.beta.-D-Ribofuranosyluracil
- Uridine-15N2
- 1-beta-D-Ribofuranosylpyrimidine-2,4(1H,3H)-dione (Uridine)
- araU
- Uridine-t
- d-Ribosyl uracil
- .beta.-Uridine
- Uridine (Standard)
Look up URIDINE in the interactive SynDRA portal →